Tarsons Products Hits New 52-Week Low at Rs. 279.05

Tarsons Products, a small-cap player in the healthcare services sector, has reached a new 52-week low of Rs. 279.05 on November 7, 2025. This decline marks a significant downturn for the stock, which has underperformed its sector by 0.9% today. Over the past five days, Tarsons Products has seen a consecutive fall, with returns decreasing by 3.66%. The stock's performance over the past year has been notably poor, with a decline of 35.67%, contrasting sharply with the Sensex's positive performance of 4.02% during the same period. Tarsons Products is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a sustained downward trend. Financial metrics reveal challenges for the company, including a low Return on Capital Employed (ROCE) of 8.12% and a significant drop in operating profit growth over the last five years. Additionally, the company has experienced a decrease in institutional investor participation, with a 3.27% reduction in stakes over the previous quarter. As Tarsons Products navigates these financial hurdles, its market position remains under scrutiny.